Back to Results
First PageMeta Content
Health / Spinal muscular atrophy / SMN1 / Mipomersen / Survival of motor neuron / Duchenne muscular dystrophy / Amyotrophic lateral sclerosis / Atrophy / Muscular dystrophy / Motor neurone disease / Genetic genealogy / Medical genetics


ISIS INITIATES PHASE 1 CLINICAL STUDY OF ISIS-SMNRX IN PATIENTS WITH SPINAL MUSCULAR ATROPHY U.S. FDA has granted both Fast Track Status and Orphan Drug Designation for ISIS-SMNRx CARLSBAD, Calif., December 19, 2011 –
Add to Reading List

Document Date: 2013-04-29 02:31:35

Open Document

File Size: 137,73 KB

Share Result on Facebook

City

CARLSBAD / Long Island / /

Company

CSHL Press / Motor Neuron Center / Thomson Reuters / Genzyme / Cold Spring Harbor Laboratory / Isis Pharmaceuticals Inc. / /

Continent

Europe / /

Country

Japan / United States / /

Currency

USD / /

Event

FDA Phase / Business Partnership / /

Facility

ABOUT THE UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL The University of Massachusetts Medical School / Columbia University Medical Center / University of Massachusetts Medical School / Motor Neuron Center / /

IndustryTerm

treatment for this serious disease / antisense technology / /

MedicalCondition

severe motor-neuron disease / muscle weakness / simple respiratory infections / amyotrophic lateral sclerosis / cystic fibrosis / orphan disease / cancer / spinal muscular atrophy / rare/neurodegenerative diseases / disease / respiratory failure / serious disease / severe genetic disease / Duchenne’s muscular dystrophy / diseases / /

MedicalTreatment

physical therapy / /

OperatingSystem

Isis / /

Organization

UNIVERSITY OF MASSACHUSETTS / Muscular Dystrophy Association / Intrathecal administration / United States Food and Drug Administration / Families of SMA / SMA Foundation / Columbia University Medical Center / FDA / University of Massachusetts Medical School / /

Person

Karen S. Chen / Craig C. Mello / Darryl C. De Vivo / Kenneth Hobby / Valerie Cwik / C. Frank Bennett / Adrian Krainer / /

Position

Executive Vice President Research and Medical Director / President / Co-Director / Professor of Molecular Genetics / Chief Scientific Officer / Professor of Neurology / Governor / leader / Senior Vice President of Research / /

Product

ISIS-SMNRx / SOD1Rx / ISIS-SMNRX IN PATIENTS / /

ProvinceOrState

New York / California / /

PublishedMedium

U.S.News & World Report / /

Technology

neuroscience / antisense technology / human genome / /

URL

www.isispharm.com / www.cshl.edu / www.clinicaltrials.gov / www.umassmed.edu / /

SocialTag